Agilent, Applied Spectral Imaging Enter FISH Marketing Agreement
Agilent Technologies Inc. and Applied Spectral Imaging (ASI) Inc. have entered into a marketing agreement for ASI’s GenASIs imaging platforms and Agilent’s fluorescence in situ hybridization (FISH) products.
“Difficulty of fluorescence-based molecular analysis has always been a major pain point for our customers,” said Herman Verrelst, vice president and general manager of Agilent’s genomics solutions and clinical applications divisions.
The agreement includes the marketing of Agilent’s Dako Omnis instrument for automated FISH sample processing.
ASI is a developer of imaging solutions for fluorescent, bright-field and spectral image acquisition in karyotyping, FISH and other pathology tests. Agilent provides instruments for the life sciences, diagnostics and applied chemical markets.
LATEST NEWS
- Quantinuum Launches 56-Qubit Quantum Computer: Week in Brief: 6/7/2024
Jun 7, 2024
- Atom Computing Lands Investment, Expands Overseas
Jun 7, 2024
- Optogenetic Stimulation Enables Fatigue-Resistant Muscle Control
Jun 6, 2024
- Quandela Launches Pilot Line for Qubit Devices
Jun 6, 2024
- Lattice Semiconductor Adds Interim CEO
Jun 6, 2024
- On-Chip Microcomb Laser Provides Greater Control
Jun 5, 2024
- Flexible, Stretchable Device Addresses Tuning Limitations in Structural Color
Jun 5, 2024
- Fusion Startup Xcimer Raises $100M, Plans Laser Prototype
Jun 4, 2024